Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Serum and Ocular Coherence Tomography Biomarkers in Patients With Diabetic Macular Edema Treated With Anti-VEGF or Dexamethasone Implant

NCT06984822 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06984822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06984822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Serum and Ocular Coherence Tomography Biomarkers in Patients With Diabetic Macular Edema Treated With Anti-VEGF or Dexamethasone Implant
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2025
Completion date
December 31, 2028
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic macular edema, hyperglycaemia (diabetic), oxidative stress, vascular endothelial growth factor, vegf, visual impairment